Thu, Dec 09, 2021
Indian drugmaker Biocon Ltd is in talks with generic drugmaker Mylan for a merger of their biosimilar businesses, a financial news website reported on Thursday, citing sources with direct knowledge of the matter.
More >
Wed, Feb 07, 2018
The study of YLB113 was a multinational randomised double-blind controlled trial of 52 weeks duratio
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
